ce-spotlight

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.

---------------------------------

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------

banner rdc


	This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline), track and print your professional transcript and more…

Pharmacist e-Link CE Spotlight

The Vitamin D and Calcium Crisis: Strategies to Improve Bone Health
The goal of this educational strategy is to increase attention and understanding of the role of nutrition, calcium and vitamin D in bone health in order to prevent and reduce bone disease and promote evidence-based information to encourage these changes.
Supporting Organizations: Merck & Co., Inc. and Pharmavite

The Health Professional's Role in Formulary Management of Medicare Part D Benefits
Pharmacists are confronting many challenges with the new Medicare Prescription Drug Benefit. Among the most time consuming are formulary management, prior authorization requirements, step therapy protocols, and tight formularies. Most Medicare beneficiaries will encounter new formulary requirements, so preparation will be key for pharmacists during their patient's transition to Medicare Part D when they will be in the crucial position of interacting between the plan, prescriber, and patient to lessen any delays in drug coverage.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Other Featured CE

Insulin Delivery Systems and Their Role in the Treatment of Diabetes
The goal of this activity is to provide healthcare professionals with information on current and investigational methods of insulin delivery to help them guide patients in selecting the most suitable method of insulin delivery.
This program is supported by an educational grant from Novo Nordisk Inc.

Opportunities and Guidelines for Aggressive Prevention of Secondary Stroke
This 1-hour audio lecture activity, including a patient case study review, is hosted by Dr. Howard Kirshner from Vanderbilt Stroke Center and Dr. Michael Bottorff from the University of Cincinnati. This activity is designed to provide hospital pharmacists and managed markets physicians with education on the burden of primary and secondary stroke and the importance of early and aggressive stroke prevention in the hospital setting.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

The Safety of COX-2 Pharmacotherapy for Patients in Pain
There are anecdotal reports about the COX-2 inhibitors of improved efficacy over the traditional NSAIDs. This program will help the practitioner identify those patients with specific risk factors, in whom the risks would outweigh potential benefits, and properly educate those for whom COX-2 use is still an option.
This program is supported by an educational grant from Pfizer Inc.

Novel Therapies to Reduce Cardiometabolic Risk Factors
New and novel therapies are emerging that affect the endocannabinoid system (ECS). These therapies impact on the regulation of food intake and fat accumulation, as well as lipid and glucose metabolism.
This activity has been developed and provided by The GMR Group-Health Insights and is supported by an educational grant from Sanofi-Aventis.

The Role of Pharmaceuticals in Reducing Cardiometabolic Risk: Rethinking Pharmacy Benefit Design to Reduce the Burden on the Healthcare System
It is estimated that approximately 20-25 percent of the adult population has metabolic syndrome. Cardiovascular disease, the number one killer of people with metabolic syndrome and the leading cause of death in the US, is associated with nearly $400 billion in direct and indirect costs. To avoid escalating costs, employers and managed care organizations must reevaluate their approach to benefit design. An innovative pharmacy benefit plan that improves access to cost-effective pharmaceuticals is a critical component in the prevention of cardiovascular disease.
The program is sponsored by the Benefit Design Institute and is supported through an educational grant from sanofi-aventis.

NCPA’s Medicare Rx Forum: A Briefing and Town Hall Discussion on the New Prescription Drug Benefit
The Medicare Modernization Act of 2003 (MMA) will have an enormous effect on community pharmacy. This informative program will prepare the community pharmacist with the vital information that they need to educate their beneficiaries to the effects that the MMA will have on their lives and how to best deal with Medicare Part D.